LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors
Clinical trial NCT00556088 · COMPLETED
Trial details
- NCT number
- NCT00556088
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.